Cabazitaxel (CBZ) in metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (Doc): Single CUP center results
作者
Anna Ntokou,Dimosthenis Zylis,Lambros I Markos,Serafeim Kaltsas,Sofia Stamatopoulou,Eleni Pouliou,N. Agrogianni,K. Florou,Despina Gkeka,H. Stavrinidis,Alexandros S Ardavanis